title: What's new in TB?
abstract: BACKGROUND
  Australia has among the world's lowest rates of tuberculosis (TB). However, it remains a leading global cause of morbidity and mortality. In Australia, TB remains more common in Indigenous than non-Indigenous Australians, and rates are rising among migrants, reflecting changing immigration patterns and rising rates in their homelands.
  
  
  OBJECTIVE
  This article reviews recent developments in TB of relevance to Australian general practice and provides an update of advances in the diagnosis and management of TB, and the role of the general practitioners in co-managing people with TB.
  
  
  CONCLUSIONS
  First hand experience with imported multidrug resistant TB (MDR-TB) is increasing and is anticipated to rise in Australia. The reach of extensively drug resistant TB is also expanding. Although standard guidelines for management of drug susceptible TB remain unchanged, recent progress in the understanding, diagnosis and management of TB has occurred, driven by the need to respond to the challenges of MDR-TB and HIV-TB co-infection.
authors.affiliation: National Centre for Epidemiology and Population Health, Australian National University, Australia. anna.ralph@anu.edu.au
authors.forename: Anna
authors.initials: A
authors.lastname: Ralph
authors.forename: Paul
authors.initials: P
authors.lastname: Kelly
authors.forename: Vicki
authors.initials: V
authors.lastname: Krause
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D019468:Disease Management; D005194:Family Practice; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents